Design and structural optimization of novel 2H-benzo[h]chromene derivatives that target AcrB and reverse bacterial multidrug resistance

Yinhu Wang,Rawaf Alenazy,Xinjie Gu,Steven W Polyak,Panpan Zhang,Matthew J Sykes,Na Zhang,Henrietta Venter,Shutao Ma,Steven W. Polyak,Matthew J. Sykes

DOI: https://doi.org/10.1016/j.ejmech.2020.113049

IF: 7.088

2021-03-01

European Journal of Medicinal Chemistry

Abstract:<p>Drug efflux pumps have emerged as a new drug targets for the treatment of bacterial infections in view of its critical role in promoting multidrug resistance. Herein, novel chromanone and 2<em>H-</em>benzo[h]chromene derivatives were designed by means of integrated molecular design and structure-based pharmacophore modeling in an attempt to identify improved efflux pump inhibitors that target <em>Escherichia coli</em> AcrB. The compounds were tested for their efflux inhibitory activity, ability to inhibit efflux, and the effect on bacterial outer and inner membranes. Twenty-three novel structures were identified that synergized with antibacterials tested, inhibit Nile red efflux, and acted specifically on the AcrB. Among them, <strong>WK2</strong>, <strong>WL7</strong> and <strong>WL10</strong> exhibiting broad-spectrum and high-efficiency efflux inhibitory activity were identified as potential ideal AcrB inhibitors. Molecular modeling further revealed that the strong π-π stacking interactions and hydrogen bond networks were the major contributors to tight binding of AcrB.</p>

chemistry, medicinal